Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while GraniteShares 2x Long NVDA Daily ETF trades at $33.35 (market cap $3.52B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.8× GraniteShares 2x Long NVDA Daily ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals.
| GEHC | NVDL | |
|---|---|---|
Market Cap | $31.07B | $3.52B |
Volume | 3,443,020 | 6,205,788 |
Sector | Health | Leveraged / Inverse |
52-Week High | $88.16 | $43.02 |
52-Week Low | $59.48 | $21.76 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.58 with a 1.81% daily gain. Technical indicators show a bullish overall signal with mixed moving averages and neutral oscillators. The ETF tracks Nvidia's performance with 2x daily leverage, though recent articles highlight it underperformed NVDA's 22.21% one-year return with only 17.21%. Recent news focuses on Nvidia's strong earnings and AI leadership driving optimism.
The outlook remains tied to Nvidia's AI dominance and earnings momentum, offering leveraged exposure to chip sector growth. Key risks include leverage decay, tracking error, and Nvidia's high valuation sensitivity. Investors should weigh the ETF's daily reset mechanism against long-term holding costs amid volatile tech markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
